Type
1.
Singh I, Yadav AR, Mohanty KK, Katoch K, Bisht D, Sharma P, et al. Molecular mimicry between HSP 65 of Mycobacterium leprae and cytokeratin 10 of the host keratin; role in pathogenesis of leprosy. Cellular immunology. 2012;278(1-2):63-75.
Type
1.
Moraes MO, Sarno EN, Jardim MR, Rosa PS, Shannon E, Ribeiro-Alves M, et al. Gene expression profiling specifies chemokine, mitochondrial and lipid metabolism signatures in leprosy. PloS one [Internet]. 2013;8(6):e64748. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683049/pdf/pone.0064748.pdf
Type
1.
Merlier-Haïm. Le voyage de Strawberry. Cerises Et Coquelicots; 2009.
Type
1.
Duĭko. [The characteristics of organization of anti-leprosy activities in Russia]. Problemy sotsial’noi gigieny, zdravookhraneniia i istorii meditsiny. 2013;(2):31-2.
Type
1.
Sabandar C, Ahmat N, Jaafar FM, Sahidin. Medicinal property, phytochemistry and pharmacology of several Jatropha species (Euphorbiaceae): A review. Phytochemistry. 2012;
Type
1.
Wiwanitkit V. Oral health status in leprosy. Indian journal of leprosy [Internet]. 2013;85(1):37. Available from: http://www.ijl.org.in/oct-dec/7%20Letter%20to%20Editor%20(37)%20f.pdf
Type
1.
Saraya M, Al-Fadhli M, Qasem J. Diabetic status of patients with leprosy in Kuwait. Journal of infection and public health. 2012;5(5):360-5.
Type
1.
Law AS. Kalaupapa: A collective memory. University of Hawaii Press,; 2012.
Type
1.
Brandsma W, Bhattarai, Anderson. Skin lesions in proximity to nerves at risk in leprosy: a reason to start immunosuppressive drugs and an indicator to the transmission of leprosy? Indian journal of leprosy. 2007;79(4):185-94.
Type
1.
Marasini. Health and hospital development in Nepal. Journal of Nepal Medical Association. 2003;42:306-11.
Pagination
- Previous page
- Page 414
- Next page